Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,138 total articles
Varonis Systems, Inc., a leader in data and AI security, will participate in several upcoming investor conferences including J.P. Morgan, TD Cowen, and William Blair in the US. Presentations will cover the company's AI security solutions and will be webcast live.
Black Rock Coffee Bar announced the appointment of Jon Vingo as Chief Development Officer to lead its restaurant development strategy. With over two decades of experience in multi-unit restaurant growth and operations, Vingo will oversee real estate, site selection, prototype design, and construction. This move supports Black Rock Coffee Bar’s goal…
Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company specializing in oral delivery of biologics and drugs via its proprietary RaniPill® technology, announced participation in the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. The management team will present via a fireside chat and one-on-one meetin…
Kyverna Therapeutics announced the initiation of a rolling Biologics License Application (BLA) submission to the FDA for its CAR T-cell therapy, mivocabtagene autoleucel (miv-cel), targeting stiff person syndrome (SPS). The company gained FDA alignment on the regulatory path following a positive pre-BLA meeting. Recent trial data demonstrated robus…
CSX Corporation's Board of Directors has approved a quarterly dividend of $0.14 per share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. CSX is a major transportation company specializing in rail, intermodal, and rail-to-truck transload services across various sectors including energy, industrial, construction, agricultura…
Kura Oncology posted $5.8 million in net product revenue from KOMZIFTI in the first full quarter since commercialization, showing strong physician adoption and payer coverage. The company is advancing multiple clinical trials for ziftomenib in AML, with anticipated 2026 data readouts supporting its broad use. The robust cash position and collaborat…
Aura Biosciences, a clinical-stage biotech company specializing in precision therapies for solid tumors, announced that its senior management will participate in two major investor conferences in May 2026 to discuss the company's developments and outlook. Live webcasts will be available and archived on the company's investor relations website.
IZEA Worldwide reported a Q1 2026 revenue of $6.6 million, an 18% decrease year-over-year, reflecting their strategic shift away from low-margin SMB accounts toward higher-value enterprise clients. Despite the revenue decline and a net loss of $0.8 million, the company launched ZED, an AI-powered marketing platform, secured new major clients, and m…
Pacira BioSciences issued a letter to its stockholders ahead of the 2026 Annual Meeting, advocating for votes in favor of its three board nominees. The company emphasizes the nominees' extensive experience in healthcare and biopharmaceutical sectors aligned with Pacira's strategic goals, contrasted against the underqualified nominees proposed by ac…
Inhibikase Therapeutics announced the commencement of its pivotal Phase 3 IMPROVE-PAH clinical trial targeting Pulmonary Arterial Hypertension (PAH) with its lead candidate IKT-001. The company secured regulatory approvals across 16 countries including the US and EU, benefiting from the EMA's FAST-EU initiative to expedite trial sites activation. F…
Verrica Pharmaceuticals reported a 51.3% year-over-year increase in dispensed YCANTH applicator units and $5.0 million revenue in Q1 2026, highlighting growing adoption of their FDA-approved treatment for molluscum. The company advanced its global Phase 3 trial enrollment for YCANTH's new use in common warts and expanded commercial launch into Japa…
OptimizeRx Corp. reported Q1 2026 revenue of $19.8 million, a 10% decrease year-on-year, but achieved a narrowed GAAP net loss of $0.5 million and increased adjusted EBITDA to $3.3 million. The company updated its fiscal year 2026 revenue guidance higher to $95-$100 million while maintaining adjusted EBITDA guidance at $21-$25 million. Subsequent t…
Nkarta, Inc. reported its Q1 2026 financial results and corporate updates, highlighting progress in its NKX019 clinical trials (Ntrust-1 and Ntrust-2) for autoimmune diseases. The company secured FDA agreement for outpatient dosing, protocol amendments including re-dosing and expanded indications, and obtained multiple IRB approvals. Nkarta maintai…
BIO-key International's Nasdaq-listed shares (BKYI) will be suspended as of May 12, 2026, due to the stock price failing to maintain Nasdaq's $1 minimum bid price for the required duration and delays in filing its annual report. The company will temporarily trade on the OTC Markets while seeking to restore its Nasdaq listing. Despite the suspension…
Maze Therapeutics announced positive topline Phase 2 trial data for MZE829 in APOL1-mediated kidney disease (AMKD), demonstrating clinical proof-of-concept and supporting advancement to a pivotal trial. It plans to start Phase 2 trials for MZE782 in phenylketonuria (PKU) and chronic kidney disease (CKD) in 2026, with topline data expected in 2027. …
Cytokinetics announced participation in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference. The company highlighted progress on its cardiac drug candidates, including the approved MYQORZO® (aficamten) for obstructive hypertrophic cardiomyopathy and positive Phase 3 results for aficamten in non-obstructive HCM. They continu…
Molecular Partners reports progress in its lead Radio-DARPin MP0712 with a Phase 1/2a study underway in multiple US clinical sites and initial data expected in 2026. The company unveiled an isotope-agnostic Radio-DARPin strategy enabling flexible therapeutic payloads and strengthened its financial position with CHF 79 million cash, supporting pipel…
South Jersey Industries, Inc. announced a cash tender offer to repurchase all outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031 at $920 per $1,000 principal amount plus accrued interest. The offer aims to refinance debt subject to market and legal conditions, with no minimum tender amount required. The tender will expi…
IDT Corporation’s BOSS Money digital remittance service achieved record remittances sent to Mother’s Day destinations, with a 49% increase in principal and 27% more transactions compared to last year, emphasizing strong growth in their digital remittance business and expanding customer trust.
22nd Century Group, Inc. announced that the FDA has accepted for scientific review the company's renewal applications for their VLN® King and VLN® Menthol King cigarettes, the first combusted cigarettes authorized as Modified Risk Tobacco Products (MRTP). These renewals, if approved, will allow continued marketing of these reduced nicotine cigarett…
Skye Bioscience reported Q1 2026 financial results and provided a business update focusing on the advancement of its nimacimab obesity treatment program. The company initiated enrollment in Cohort 1 of the CBeyond Expansion Study, completed compatibility studies to support subcutaneous delivery, and is on track to report topline data in Q4 2026. Sk…
SEGG Media, a Nasdaq-listed sports and entertainment company, announced its expanded partnership with Soccerex by becoming the official headline sponsor for all 2026 and 2027 Soccerex events. The company is actively participating in Soccerex Europe 2026 in Amsterdam, engaging with key football stakeholders to grow its sports media and fan engagemen…
South Jersey Industries, Inc. has announced a cash tender offer to repurchase any and all of its outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031 at $92 per $1,000 principal amount plus accrued interest. The offer expires on May 26, 2026, with settlement on May 29, 2026. Completion of the tender is contingent upon cer…
Kyivstar Group Ltd., Ukraine's leading digital operator listed on Nasdaq, held its 2026 Annual General Meeting where shareholders re-elected the current board and Chairman Kaan Terzioğlu, demonstrating continued confidence in the company's strategic direction. Kyivstar reported strong 2025 financial results with a 25.9% increase in revenue to USD 1…
Linkhome Holdings Inc. (Nasdaq: LHAI), an AI-driven real estate and fintech platform, has entered into a definitive agreement to acquire Mortgage One Group, a mortgage lending company operating in 18 U.S. states. This acquisition aims to integrate Mortgage One Group's lending infrastructure with Linkhome's AI technology to create an advanced AI-pow…
